Dr. Sukesh Burjonroppa, M.D.
What this data tells you about Dr. Burjonroppa
Dr. Sukesh Burjonroppa is a cardiovascular disease in Fort Worth, TX, with 19 years in practice. Based on federal Medicare data, Dr. Burjonroppa performed 3,650 Medicare services across 2,596 unique beneficiaries.
Between the years covered by Open Payments, Dr. Burjonroppa received a total of $156,825 from 27 pharmaceutical and/or device companies across 489 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Burjonroppa is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) | 615 | $63 | $156 |
| Electrocardiogram (EKG), 12-lead | 605 | $10 | $42 |
| Office visit, established patient (30-39 min) | 412 | $88 | $231 |
| Hospital follow-up visit, moderate complexity | 235 | $60 | $155 |
| Regadenoson injection (Lexiscan) for heart stress test | 216 | $44 | $120 |
| Echocardiogram, transthoracic | 150 | $142 | $471 |
| Hospital follow-up visit, high complexity | 142 | $91 | $223 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 103 | $9 | $150 |
| Telephone medical discussion with physician, 5-10 minutes | 78 | $38 | $65 |
| Initial hospital admission, high complexity | 74 | $131 | $434 |
| Ultrasonic guidance for blood vessel access | 70 | $11 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 64 | $2 | $30 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 61 | $51 | $196 |
| Replacement of aortic valve through the skin and femoral artery | 57 | $567 | $3,097 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 56 | $25 | $45 |
| Ultrasound of heart blood flow, valves and chambers | 54 | $13 | $42 |
| Ultrasound of heart with probe in esophagus, with report | 52 | $80 | $237 |
| New patient office visit, complex (60-74 min) | 49 | $158 | $442 |
| Office visit, established patient (10-19 min) | 44 | $41 | $94 |
| Ultrasound of both sides of head and neck blood flow | 38 | $119 | $554 |
| Office visit, established patient, complex (40-54 min) | 38 | $136 | $310 |
| Hospital discharge management, 30+ min | 36 | $89 | $226 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 32 | $246 | $764 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 31 | $343 | $1,111 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 30 | $171 | $234 |
| Coronary stent placement | 29 | $378 | $1,280 |
| New patient office visit (45-59 min) | 29 | $112 | $355 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 29 | $681 | $1,034 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 28 | $17 | $75 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 25 | $1,058 | $2,490 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 21 | $661 | $900 |
| Ultrasound of heart, follow-up | 19 | $19 | $102 |
| Cardiac catheterization | 19 | $157 | $600 |
| Ultrasound of leg arteries or artery grafts | 18 | $163 | $700 |
| Placement and subsequent removal of device to protect brain from embolism through catheter using imaging guidance | 15 | $101 | $295 |
| 3d radiographic procedure | 14 | $7 | $25 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 14 | $6 | $14 |
| Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | 13 | $24 | $60 |
| Repair of left upper heart chamber with implant with review by radiologist | 12 | $591 | $1,500 |
| Ultrasound study of arm and leg arteries | 12 | $51 | $245 |
| Repair of mitral valve through the skin, initial prosthesis | 11 | $1,306 | $5,470 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for cardiovascular disease in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Burjonroppa is a clinical cardiology specialist, with above-average Medicare volume (top 27% in TX), and high industry engagement (speaking/promotional, top 4%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Burjonroppa experienced with office visit, established patient (20-29 min)?
Does Dr. Burjonroppa receive payments from pharmaceutical companies?
How do Dr. Burjonroppa's costs compare to other cardiovascular diseases in Fort Worth?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology